KPC Pharmaceuticals, Inc. (600422.SS)
CNY 16.62
(0.3%)
CNY 16.62
(0.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.62 Billion | 8.28 Billion | 8.25 Billion | 7.71 Billion | 8.11 Billion | 7.1 Billion |
| Cost of Revenue | 4.29 Billion | 4.84 Billion | 4.84 Billion | 4.33 Billion | 4.16 Billion | 3.55 Billion |
| Gross Profit | 3.33 Billion | 3.43 Billion | 3.4 Billion | 3.38 Billion | 3.95 Billion | 3.54 Billion |
| Operating Expenses | 2.88 Billion | 2.82 Billion | 2.83 Billion | 2.83 Billion | 3.39 Billion | 3.11 Billion |
| Selling, General and Administrative Expenses | 2.7 Billion | 2.51 Billion | 2.49 Billion | 2.47 Billion | 3.08 Billion | 2.76 Billion |
| Research and Development Expenses | 71.26 Million | 69.65 Million | 100.51 Million | 128.44 Million | 83.51 Million | 77.11 Million |
| Other Expenses | -21.15 Million | 239.23 Million | 240.38 Million | 238.8 Million | 228.6 Million | -2.67 Million |
| Cost and Expenses | 7.13 Billion | 7.66 Billion | 7.67 Billion | 7.17 Billion | 7.56 Billion | 6.66 Billion |
| Operating Income | 568.49 Million | 497.14 Million | 634.04 Million | 540.83 Million | 539.8 Million | 419.81 Million |
| Interest Expense | 19.3 Million | 40.73 Million | 33.58 Million | 29.16 Million | 40.41 Million | 41.49 Million |
| Income Tax Expense | 109.47 Million | 91.82 Million | 118.07 Million | 78.3 Million | 76.67 Million | 75.45 Million |
| Earnings before Tax | 563.61 Million | 477.28 Million | 631.28 Million | 540.48 Million | 544.43 Million | 417.13 Million |
| Net Income | 444.67 Million | 383.18 Million | 507.66 Million | 456.85 Million | 454.3 Million | 335.53 Million |
| Earnings Per Share Basic | 0.59 | 0.51 | 0.67 | 0.60 | 0.60 | 0.44 |
| Earnings Per Share Diluted | 0.59 | 0.51 | 0.67 | 0.60 | 0.60 | 0.44 |
| Weighted Average Shares Outstanding | 753.69 Million | 751.34 Million | 758.25 Million | 759.14 Million | 761.36 Million | 768.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 753.69 Million | 751.34 Million | 758.25 Million | 759.14 Million | 761.62 Million | 768.52 Million |
| Gross Margin | 0.44 | 0.42 | 0.41 | 0.44 | 0.49 | 0.50 |
| EBIT Margin | 0.11 | 0.10 | 0.11 | 0.09 | 0.09 | 0.08 |
| Profit Margin | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 |
| EBITDA | 801.81 Million | 726.81 Million | 870.94 Million | 757.04 Million | 727.35 Million | 558.76 Million |
| Earnings Before Tax Margin | 0.07 | 0.06 | 0.08 | 0.07 | 0.07 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.9 Billion | 1.68 Billion | 1.83 Billion | 2.07 Billion | 7.62 Billion | 1.84 Billion |
| Cost of Revenue | 1.13 Billion | 1.03 Billion | 1.08 Billion | 1.19 Billion | 4.34 Billion | 1 Billion |
| Gross Profit | 771.74 Million | 651.24 Million | 746.67 Million | 873.99 Million | 3.28 Billion | 832.44 Million |
| Operating Expenses | 548.84 Million | 585.35 Million | 601.49 Million | 832.52 Million | 2.81 Billion | 618.28 Million |
| Selling, General and Administrative Expenses | 840.83 Million | 558.34 Million | 578 Million | 753.52 Million | - | 750.42 Million |
| Research and Development Expenses | 21.87 Million | 18.28 Million | 17.21 Million | 26.87 Million | - | 12.75 Million |
| Other Expenses | -313.86 Million | -8.72 Million | -6.26 Million | -52.12 Million | -42.95 Million | -975.75 Thousand |
| Cost and Expenses | 1.68 Billion | 1.61 Billion | 1.69 Billion | 2.03 Billion | 7.15 Billion | 1.62 Billion |
| Operating Income | 203.21 Million | 65.88 Million | 145.18 Million | 41.47 Million | 471.25 Million | 194.32 Million |
| Interest Expense | 7.34 Million | 6.6 Million | 6.56 Million | 10.23 Million | 24.38 Million | -3.02 Million |
| Income Tax Expense | 56.27 Million | 23.89 Million | 26.82 Million | 28.92 Million | 109.47 Million | 27.64 Million |
| Earnings before Tax | 213.07 Million | 136.65 Million | 147.83 Million | 86.61 Million | 563.8 Million | 193.34 Million |
| Net Income | 157.91 Million | 110.78 Million | 118.69 Million | 58.67 Million | 444.67 Million | 162.63 Million |
| Earnings Per Share Basic | 0.21 | 0.15 | 0.16 | 0.08 | - | 0.21 |
| Earnings Per Share Diluted | 0.21 | 0.15 | 0.16 | 0.08 | - | 0.21 |
| Weighted Average Shares Outstanding | 757.02 Million | 757.11 Million | 757.11 Million | 766.16 Million | 758.09 Million | 757.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 757.02 Million | 757.11 Million | 757.11 Million | 766.16 Million | 758.09 Million | 757.98 Million |
| Gross Margin | 0.41 | 0.39 | 0.41 | 0.42 | 0.43 | 0.45 |
| EBIT Margin | 0.12 | 0.07 | 0.10 | 0.05 | - | 0.11 |
| Profit Margin | 0.08 | 0.07 | 0.06 | 0.03 | 0.06 | 0.09 |
| EBITDA | 220.42 Million | 117.25 Million | 186.27 Million | 95.23 Million | - | 208.38 Million |
| Earnings Before Tax Margin | 0.11 | 0.04 | 0.08 | 0.02 | 0.06 | 0.11 |
9533
CANS
STO3
ABEO
SZCRF
SDOT